Medtronic Plc

Medtronic Plc

MDTNYSEHealthcare
$94.75
down -0.7 (-0.73%)

1-Year Price

-0.06% past year
Medtronic Plc (MDT) 1-year price chart: down 0.06% from $94.81 on Oct 2025 to $94.75 on Oct 2026. Closing range $73.75 to $105.35.

EquityGlimpse Score

Overall
6.3/10
Wide Moat

Strong, durable competitive advantages versus peers.

Growth
4

Valuation, profitability, financial health, dividend and sentiment scores for Medtronic Plc (MDT) are available to EquityGlimpse members.

Market Cap
121.2B
P/E Ratio
22.22
EPS
$3.74
52W High
$106.33
52W Low
$73.31
Volume
29.74M
Beta
0.57
Dividend Yield
3.41%
Fair value estimate: sign up to see
Is MDT over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
2.94
Price to Book
2.16
EV/EBITDA
13.54
Free CF per Share
$4.23
Op. CF per Share
$5.72
Debt to Equity
0.57
Gross Margin
65.02%
Net Margin
13.20%

About Medtronic Plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

CEO
Geoffrey Straub Martha
Industry
Medical - Devices
Employees
95,000
IPO Date
1973-05-02
Country
IE
Unlock Full Analysis

Get the complete picture on Medtronic Plc

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for MDT and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling

Starting at $8.25/month. 7-day free trial. Cancel anytime.